$CBIS a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce updates to its 2017 Gala.
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!